I feel that I have been able to prove beyond any doubt that MHRA’s advice to government to ban Co-proxamol was in order to increase their income and NOT FOR DRUG SAFETY CONCERNS OR EFFICACY!
Dextropropoxyphene based products are back in production in India and on the market at a very completive price, £1.13 /100 tablets
MHRA’s scare tactics were totally responsible for the scandalous price increases (£49.50) when the product was finally removed from the NHS prescribing list. For this reason the ‘Named Patient Facility’ should be reinstated immediately and the suitability for controlled status for general use. Co-proxamol should be considered to be far safer than Tramadol, Oxycodone, Fentanyl, and Buprenorphine Which MHRA have issued 298 additional ‘Marketing Authorisations’ since the ban on Co-proxamol was announced in 2005!
It should also be noted that there was a total lack of ‘due diligence’ by ministers when they decided to accept MHRA’s seriously flawed recommendations regarding Co-proxamol.
Ministers Directly Responsible For the Lack of Due Diligence
Patricia Hewitt 5 May 2005 – 27 June 2007
Alan Johnson Secretary of State for Health Jun 2007 - Jun 2009
Caroline Flint Minister for Public Health from 2005 to 2007
Dawn Primarolo Minister for Public Health 2007–2009
Secretary of State for Health Jeremy Hunt, my MP Paul Maynard, PrescQIPP, LMMG, CCG, DOH, and the NHS have all acted in a disgraceful manner by refusing to confront the MHRA regarding the MISSINFORMATION they have peddled since 2005; MHRA have had a complete disregard for patient’s safety and wellbeing, and the colossal increased costs which have burdened the NHS throughout this sad state of affairs!
MHRA are nothing more than a REPREHENSIBLE MONEY GRUBBING ORGANISATION IN CAHOOTS WITH BIG PHARMA and are totally devoid of a moral conscience regarding patient safety and wellbeing. They are totally responsible making life intolerable for millions of patients globally!
* Medindia Drugs Drug Price
Caybutyl (Dextropropoxyphene) Double Strength 1 Tab Max 4 Daily
100 Tabs = 97 INR = 1.13092 GBP
Indian Rupee1 INR = 0.0116590 GBP
Price List Updated on February 2nd 2017
Drug information on Caybutyl (Dextropropoxyphene) from Jagsonpal Pharmaceuticals Ltd.
Combination of Generics - Dextropropoxyphene, Paracetamol
Drug information on Brudex (400+325+32.5) (Dextropropoxyphene - Combination) from PRG Pharma Pvt Ltd.
Combination of Generics - Dextropropoxyphene, Ibuprofen, Paracetamol
Brudex (400+325+32.5)
Trade Name Brudex (400+325+32.5)
Manufacturer PRG Pharma Pvt Ltd.
Unit 400mg/325mg/32.5mg
___________________________
There should be hope for the Millions of patients who have been denied Co-proxamol for the past ten years!
Caybutyl is a combination prescription 650mg/65mg Paracetamol/ Dextropropoxyphene and comes as a tablet or capsule. A single tablet would be equivalent to the Co-proxamol dose of 2 x 325 /32.5mg.
I have recently been in contact with the Parliamentary Health Committee and the Ombudsman and I would appreciate anyone who has been affected by this ban to contact their GP and MP immediately as PESTER POWER MAY GET CO-PROXAMOL REINSTATED QUICKER FOR EVERYONE WHO NEEDS IT!
Written by
Whowillgiveastuff
To view profiles and participate in discussions please or .
Reading the literature I thought that it was the small difference between the maximum dose and toxic dose that made it so dangerous. A small miscalculation or forgetfulness (have I taken another dose?) could be fatal. Decisions like this are taken because sometimes people make mistakes.
MHRA’s scare tactics were totally responsible for the scandalous price increases (from £2.30 to £49.50 when the product was finally removed from the NHS prescribing list).
Co-proxamol had been a completely safe (when tolerated and used correctly) and economical drug which had been used by patients for over 50 years!
Remuneration and pension interests of the thirteen most senior managers at MHRA range from £105,000 to £210,000.
Dr Ian Hudson Chief Executive
2016 Salary, Performance pay, and Pension related benefits amounted to a total of £220,000 - £225,000!
Dr June Raine, CBE Director of Vigilance & Risk Management of Medicines 2016 Salary, Performance pay, and Pension related benefits amounted to a total of £165.000 - £170,000!
It would be obvious to assume MHRA couldn’t afford to pay the exorbitant salaries from drugs which could only generate a low income. This was certainly the case with Co-proxamol its financial contribution to MHRA had declined to a total of just one hundred thousand pounds for the period 2005 and 2015!
MHRA have Issued 298 additional Marketing Authorisations (Licences) for three of the far more dangerous opiates, Oxycodone, Fentanyl, and Buprenorphine Since the ban on Co-proxamol was first announced!
The NHS has had to bear the excessive additional costs to operate MHRA’s ‘Named Patient Scheme’ along with the increased costs for the inferior medication thrust upon patients and the additional prescriptions added to combat the severe side effects of the alternate drugs
60,000 patients who had proved that Co-proxamol was their only effective option for pain relief and were lucky to be on 'The Named Patient Scheme' have simply been abandoned!
The number of patients admitted for opioid poisoning have risen year on year since 2005, there were 4,891 admissions in 2005-06 reaching 12,254 in 2013, 7363 additional admissions no doubt costing NHS many more millions of pounds!
Manufacture and sale of Dextropropoxyphene based products. (Darvon / Co-proxamol) was banned in India during 2013 by the Drugs Technical Advisory Board (DTAB). The UK 'Named Patient' facility relied on imports from India from 2008.
In order for the 'Named Patient' scheme to continue the NHS had to Import from Australia until production resumed in India. Production began again during 2016 following the collapse of the Indian palliative care system.
The majority of rheumatoid arthritis sufferers want is effective analgesia. This was deliberately taken away from 1.75 million UK patients by MHRA in order to increase their own income and allow the 'Giant Pharma' companies to ‘Rip Off’ the NHS with more expensive alternate analgesia!
Darvon / Co-proxamol was an extremrly effective analgesic and had been used by patients for over 50 years. Now it could be imported today for just £5.00 per pack. The maximum dose would be 8 tablets daily (212 per month) at a cost to the NHS of just £10.60 per month! (£127.20 annually)
Before the ban began Co-proxamol cost just £2.70, subsequent Governments had caused the price to rise to £700.00 during November 2018 and is directly responsible for the loss of the 'Named Patient' facility which had been guaranteed by Caroline Flint Minister for Public Health, and the MHRA during 2007!
THE FACTS ARE;
THE FACTS ARE PLAIN TO SEE:-
MHRA have issued 298 additional ‘Marketing Authorisations’ for far more dangerous and addictive drugs since the ban was first announced in 2005.
The number of patients admitted for opioid poisoning have risen year on year since 2005, there were 4,891 admissions in 2005-06 reaching 12,254 in 2013, 7363 additional admissions no doubt costing NHS many more millions of pounds!
•Deaths from Tramadol rose from 53 in 2005 to 240 in 2014
•Deaths from Oxycodone rose from 11 in 2005 to 53 in 2014
•Deaths from Codeine rose from 44 in 2005 to 136 in 2014
•Deaths from Fentanyl rose from 3 in 2005 to 40 in 2014
•Deaths from Buprenorphine rose from 5 in 2005 to 24 in 2014
The ban has left the NHS over eight million pounds worse off annually due to the prescription price increases! Plus the higher cost for the alternate Inferior medication, and the additional prescriptions GP's have had to issue to counter the horrendous side effects patients have had to suffer!
Further information is available on my recent petition.
I had been taking coproxamol till last December,i was told the hospital would no longer perscribe them,i was given paracetamol as an alternative. To cut a long story short am now taking dhidrocodine,paracetamol and morphine after trying lots of different drugs. Morphine is much more dangerous than coprpxamol.
Coproxamol was better for me, all the Doctors I have seen say the same,but they arnt allowed to perscribe
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Hi all, does anyone every experience rheumatoid pain in the base of the skull?
Hello back from Glastonbury!
Life back with enbrel
Back to work tomorrow...
Lower back pain and hips
